Castle Creek Arbitrage’s Cellebrite DI Ltd. Warrants CLBTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,918
Closed -$14.2K 135
2023
Q3
$14.2K Sell
10,918
-200,000
-95% -$254K ﹤0.01% 153
2023
Q2
$252K Hold
210,918
0.03% 139
2023
Q1
$185K Hold
210,918
0.02% 179
2022
Q4
$137K Hold
210,918
0.01% 241
2022
Q3
$158K Hold
210,918
0.01% 386
2022
Q2
$162K Hold
210,918
0.01% 388
2022
Q1
$264K Hold
210,918
0.01% 403
2021
Q4
$369K Hold
210,918
0.02% 415
2021
Q3
$445K Buy
+210,918
New +$485K 0.03% 356

Other funds holding CLBTW

Castle Creek Arbitrage's CLBTW Position: Q4 2023 in Review

Castle Creek Arbitrage sold out of Cellebrite DI Ltd. Warrants (CLBTW) in Q4 2023, closing a stake of 10,918 shares — an estimated $14.2K sold.

Castle Creek Arbitrage first reported a position in CLBTW in Q3 2021 and held it in 9 quarters. The position peaked at $445K in Q3 2021. 19 funds tracked by Wall St. Rank hold CLBTW as of Q4 2023.

  • Castle Creek Arbitrage reported no remaining Cellebrite DI Ltd. Warrants position as of Q4 2023 after selling out during the quarter.
  • Castle Creek Arbitrage sold 10,918 Cellebrite DI Ltd. Warrants shares in Q4 2023, an estimated $14.2K.
  • Castle Creek Arbitrage first reported a position in Cellebrite DI Ltd. Warrants in Q3 2021 and held it in 9 quarters.
  • Castle Creek Arbitrage's Cellebrite DI Ltd. Warrants position peaked at $445K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Cellebrite DI Ltd. Warrants as of Q4 2023.

Based on Castle Creek Arbitrage's 13F filing for Q4 2023.